FeesSafety
Pluang+

Invesco S&P SmallCap Energy ETF offers strong gains potential amid high oil prices and supply constraints

Market News
10 Sep 2026
Seeking Alpha
View Source
Bullish
Invesco S&P SmallCap Energy ETF offers strong gains potential amid high oil prices and supply constraints

The Invesco S&P SmallCap Energy ETF (PSCE) focuses on small-cap U.S. energy companies with minimal hedging, positioning it to benefit fully from elevated oil prices and supply shortages. With a low expense ratio of 0.29% and a 2% dividend yield, the fund is seen as a tactical energy investment with low geopolitical risk. Analyst Nikola Lapenna recommends accumulating PSCE during oil price dips, viewing it as a multi-year opportunity driven by ongoing global supply deficits and geopolitical tensions. The fund's concentrated portfolio of 33 domestic exploration and production companies is uniquely suited to capture upside in the current market environment.

More News

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir has guided its revenue for the third quarter of 2026 to reach $2.16 billion. This forecast is supported by the company's performance in the last two quarters, which suggests that actual results could surpass expectations. The strong revenue ...

Company Fundamentals
Bullish
1 hour ago
Evernorth highlights 13-year-old XRP wallet with limited merchandise and community event.

Evernorth highlights 13-year-old XRP wallet with limited merchandise and community event.

Evernorth Holdings, a Nasdaq-listed company managing a large XRP treasury, is collaborating with the Fuzzies community to release limited merchandise celebrating the historic Fuzzybear wallet activated in 2013. This initiative honors early XRP suppor...

Market News
Bullish
4 hours ago
Budoprutug shows promising early results in treating primary membranous nephropathy with good tolerance.

Budoprutug shows promising early results in treating primary membranous nephropathy with good tolerance.

Climb Bio presented Phase 2 data for budoprutug, an anti-CD19 antibody, showing effective B-cell depletion and reduction of PLA2R antibodies in primary membranous nephropathy (pMN) patients at 12 weeks. The 200 mg dose demonstrated immunologic remiss...

Company Fundamentals
Bullish
4 hours ago
Hyperliquid (HYPE) struggles to reach $90 target amid supply growth and recent price drop.

Hyperliquid (HYPE) struggles to reach $90 target amid supply growth and recent price drop.

Hyperliquid (HYPE) is currently priced around $76, needing a 19.2% rise to hit the $90 target set by many holders. Despite a strong 107% gain over 200 days, HYPE has fallen 17.1% in the last month, pressured by a growing unlocked token supply and a r...

Market News
Neutral
4 hours ago
Quebec's maple syrup reserve to run out by February, reducing buffer for production changes.

Quebec's maple syrup reserve to run out by February, reducing buffer for production changes.

Quebec's maple syrup reserve, stored in warehouses with a capacity of about 218,000 barrels, is expected to be depleted by February. This reserve helps balance supply fluctuations caused by weather, which strongly affects syrup production. Canadian s...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App